Wenguang Chang

4.2k total citations
88 papers, 3.3k citations indexed

About

Wenguang Chang is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Wenguang Chang has authored 88 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 19 papers in Physiology and 19 papers in Cancer Research. Recurrent topics in Wenguang Chang's work include Circular RNAs in diseases (14 papers), Cancer-related molecular mechanisms research (11 papers) and Berberine and alkaloids research (10 papers). Wenguang Chang is often cited by papers focused on Circular RNAs in diseases (14 papers), Cancer-related molecular mechanisms research (11 papers) and Berberine and alkaloids research (10 papers). Wenguang Chang collaborates with scholars based in China, United States and Canada. Wenguang Chang's co-authors include Jianxun Wang, Man Wang, Yuan Zhang, Grant M. Hatch, C. P. Leblond, Peifeng Li, Li Chen, Rajagopalan Srinivasan, Dandan Xiao and Fei Yu and has published in prestigious journals such as Gastroenterology, Journal of the American College of Cardiology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Wenguang Chang

87 papers receiving 3.2k citations

Peers

Wenguang Chang
Tao Jiang China
Udayan Apte United States
Zhanxiang Zhou United States
Jie Liu China
Dan Meng China
Tao Jiang China
Wenguang Chang
Citations per year, relative to Wenguang Chang Wenguang Chang (= 1×) peers Tao Jiang

Countries citing papers authored by Wenguang Chang

Since Specialization
Citations

This map shows the geographic impact of Wenguang Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenguang Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenguang Chang more than expected).

Fields of papers citing papers by Wenguang Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenguang Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenguang Chang. The network helps show where Wenguang Chang may publish in the future.

Co-authorship network of co-authors of Wenguang Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenguang Chang. A scholar is included among the top collaborators of Wenguang Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenguang Chang. Wenguang Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yajun, et al.. (2025). Ginsenoside Rg2 Alleviates HFD/STZ-Induced Diabetic Nephropathy by Inhibiting Pyroptosis via NF-κB/NLRP3 Signaling Pathways. The American Journal of Chinese Medicine. 53(3). 909–930. 3 indexed citations
2.
Zhang, Lei, et al.. (2024). Gut microbiota–lncRNA/circRNA crosstalk: implications for different diseases. Critical Reviews in Microbiology. 51(3). 499–513. 1 indexed citations
3.
Ding, Wei, Xuejuan Zhang, Dandan Xiao, & Wenguang Chang. (2023). Decreased in n‐3 DHA enriched triacylglycerol in small extracellular vesicles of diabetic patients with cardiac dysfunction. Journal of Diabetes. 15(12). 1070–1080. 6 indexed citations
4.
Zhang, Yuan, Wanpeng Yu, Wenguang Chang, et al.. (2023). Light Chain Amyloidosis–Induced Autophagy Is Mediated by the Foxo3a/Beclin-1 Pathway in Cardiomyocytes. Laboratory Investigation. 103(2). 100001–100001. 8 indexed citations
5.
Zhang, Yuan, Man Wang, & Wenguang Chang. (2022). Iron dyshomeostasis and ferroptosis in Alzheimer’s disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD. Frontiers in Pharmacology. 13. 983623–983623. 44 indexed citations
6.
Chang, Wenguang, et al.. (2022). Noncoding RNAs from tissue-derived small extracellular vesicles: Roles in diabetes and diabetic complications. Molecular Metabolism. 58. 101453–101453. 17 indexed citations
7.
Miao, Shuo, Qingsong Zhang, Wenguang Chang, & Jianxun Wang. (2021). New Insights Into Platelet-enriched miRNAs: Production, Functions, Roles in Tumors, and Potential Targets for Tumor Diagnosis and Treatment. Molecular Cancer Therapeutics. 20(8). 1359–1366. 10 indexed citations
8.
Chang, Wenguang, Dandan Xiao, Xinyu Fang, & Jianxun Wang. (2021). Phospholipids in small extracellular vesicles: emerging regulators of neurodegenerative diseases and cancer. Cytotherapy. 24(2). 93–100. 10 indexed citations
9.
Wang, Yu, Ling Li, Tao Xu, et al.. (2020). Baicalein protects cardiomyocytes from oxidative stress induced programmed necrosis by stabilizing carboxyl terminus of Hsc70-interacting protein. International Journal of Cardiology. 311. 83–90. 7 indexed citations
10.
Liu, Bingyan, Ling Li, Wei Ding, et al.. (2020). Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes. Acta Pharmacologica Sinica. 42(5). 701–714. 107 indexed citations
11.
Wang, Yu, Wenguang Chang, Ling Wang, et al.. (2019). A review of sources, multimedia distribution and health risks of novel fluorinated alternatives. Ecotoxicology and Environmental Safety. 182. 109402–109402. 249 indexed citations
12.
Wang, Yu, Wenguang Chang, Yuan Zhang, et al.. (2018). Circulating miR‐22‐5p and miR‐122‐5p are promising novel biomarkers for diagnosis of acute myocardial infarction. Journal of Cellular Physiology. 234(4). 4778–4786. 52 indexed citations
13.
Wang, Man, Shuai Jiang, Wei Wu, et al.. (2018). Non-coding RNAs Function as Immune Regulators in Teleost Fish. Frontiers in Immunology. 9. 2801–2801. 55 indexed citations
14.
Chang, Wenguang & Junfang Teng. (2018). Prox1 is essential for oligodendrocyte survival and regulates oligodendrocyte apoptosis via the regulation of NOXA. Acta Biochimica et Biophysica Sinica. 50(7). 709–717. 5 indexed citations
15.
Yu, Fei, Tao Xu, Man Wang, et al.. (2018). Function and regulation of mitofusin 2 in cardiovascular physiology and pathology. European Journal of Cell Biology. 97(7). 474–482. 10 indexed citations
16.
Wang, Man, Fei Yu, Wei Wu, et al.. (2017). Circular RNAs: A novel type of non-coding RNA and their potential implications in antiviral immunity. International Journal of Biological Sciences. 13(12). 1497–1506. 145 indexed citations
17.
Chang, Wenguang, Li Chen, & Grant M. Hatch. (2016). Berberine treatment attenuates the palmitate-mediated inhibition of glucose uptake and consumption through increased 1,2,3-triacyl-sn-glycerol synthesis and accumulation in H9c2 cardiomyocytes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(4). 352–362. 30 indexed citations
18.
Chang, Wenguang, Ming Zhang, Jing Li, et al.. (2013). Berberine improves insulin resistance in cardiomyocytes via activation of 5′-adenosine monophosphate-activated protein kinase. Metabolism. 62(8). 1159–1167. 89 indexed citations
19.
Chang, Wenguang, Ming Zhang, Jing Li, et al.. (2012). Berberine Attenuates Ischemia-Reperfusion Injury Via Regulation of Adenosine-5′-monophosphate Kinase Activity in Both Non-ischemic and Ischemic Areas of the Rat Heart. Cardiovascular Drugs and Therapy. 26(6). 467–478. 50 indexed citations
20.
Ke, Bibo, Haofeng Ji, Fei Gao, et al.. (2012). Disruption of Type-I IFN Pathway Ameliorates Preservation Damage in Mouse Orthotopic Liver Transplantation via HO-1 Dependent Mechanism. American Journal of Transplantation. 12(7). 1730–1739. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026